News
-
The American Clinical Laboratory Association Announces the Promotion of Julie Khani to Executive Vice President
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today announced the promotion of Julie Khani to Executive Vice President (EVP) by the ACLA Board of Directors for the nation’s leading organization representing clinical laboratories. Khani joined ACLA in the newly created position of Senior Vice President in 2013 to oversee the advocacy and policy operations and ACLA’s divisional vice presidents. In her newContinue Reading »... -
Congressional and Administration Leaders Address Clinical Laboratory Community on Legislative and Regulatory Initiatives Impacting Diagnostics at ACLA’s 21st Annual Conference
(Washington, D.C.) –The diagnostic community and the critical role it plays in patient diagnoses and treatment plans was the focal point of various presentations today as congressional, regulatory and administration leaders addressed meeting attendees at the American Clinical Laboratory Association’s (ACLA) 21st Annual Conference in Washington, DC. “Clinical laboratories are a critical part of the scientific innovation that has brought us to the forefrontContinue Reading »... -
ACLA Underscores Value of Diagnostic Innovation in the Administration’s FY 2017 Budget Billion Dollar Funding of Moonshot Initiative
(Washington, D.C.) – In a letter to Vice President Joe Biden following the administration’s release of the FY 2017 budget including a proposed billion dollar funding of the Moonshot initiative aimed at accelerating the effort to cure cancer, the American Clinical Laboratory Association (ACLA) emphasized the expanded role of diagnostic innovation in the research and treatment of cancer and urged the vice president toContinue Reading »... -
Letter sent to Vice-President Biden on the Cancer Moonshot Task Force
... -
Joint Statement from the Alliance For Integrity in Medicare Applauding Self-Referral Reform Proposal in the President’s FY 2017 Budget
... -
Sens. Hatch, Wyden Propose Alternative For Reporting Commercial Lab Test Prices
The Senate Finance Republican Chair and ranking Democrat proposed Wednesday (Jan. 6) a way for CMS to establish a new pay scheme for laboratory services that would increase pay rates for lab tests compared to CMS’ proposed approach. The senators also ask the agency to give labs more time to report commercial-payer rates. “We urge that CMS establish an alternative, more expansive methodology forContinue Reading »... -
ACLA Welcomes Award Winning Journalist Bob Schieffer as Keynote Speaker for 2016 Annual Conference in Nation’s Capital
WASHINGTON, DC – Amidst a line-up of speakers on payment reform for clinical laboratory services, proposed FDA regulation of laboratory developed tests and other pressing industry issues, longtime CBS news anchor, reporter and former host of Face the Nation, Bob Schieffer, will serve as the keynote address on March 3rd at the 2016 annual conference for the American Clinical Laboratory Association (ACLA). ACLA today openedContinue Reading »... -
ACLA Commends Senators Hatch and Wyden on Bipartisan Letter on Proposed PAMA Rule
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today applauded Senate Finance Committee Chairman Orrin Hatch (R-UT) and Ranking Member Ron Wyden (D-OR) for their leadership in urging the Centers for Medicare and Medicaid Services (CMS) to implement the Clinical Laboratory Fee Schedule (CLFS) provisions of the Protecting Access to Medicare Act (PAMA) consistent with the intent of Congress. The letter takes issueContinue Reading »... -
Letter Sent to CMS From Senate Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden on the PAMA Proposed Clinical Laboratory Payment Plan
... -
ACLA Praises House Bipartisan Dear Colleague on PAMA Proposed Rule, Letter Expresses Concern with Implementation Timeline, Stresses Importance of Preserving Patient Access to Important Diagnostics
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today applauded both Democrats and Republicans in the U.S. House of Representatives for signing onto a Dear Colleague letter delivered to the Centers for Medicare and Medicaid Services (CMS) that requests a delay in the implementation of the Clinical Laboratory Fee Schedule (CLFS) provisions of the Protecting Access to Medicare Act (PAMA) of 2014. TheContinue Reading »...
